A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by the FDA, and the partners have now withdrawn a filing intended to get ...

Daiichi Sankyo signs a $300m deal with Alteogen to develop a subcutaneous version of anti-HER2 cancer drug Enhertu. Skip to main content Friday 27 June 2025 . BlueSky linkedin youtube rss ...

View today's Dai-Ichi Cutter Kogyo KK stock price and latest 1716 news and analysis. Create real-time notifications to follow any changes in the live stock price.

Dai Ichi Karkaria is trading 1.01% upper at Rs 390.00 as compared to its last closing price. Dai Ichi Karkaria has been trading in the price range of 395.00 & 386.50. Dai Ichi Karkaria has given-1 ...

About the Dai-Ichi Life Holdings Inc.-Bond (USJ09748AD66) The Dai-Ichi Life Holdings Inc.-Bond has a I18N_bonds#descriptiontext#maturitydatepart#undefinedmaturitydate and offers a coupon of 4.0000%.

See the latest Dai-ichi Life Holdings Inc stock price (8750:XTKS), related news, valuation, dividends and more to help you make your investing decisions. Morningstar brands and products ...

Rod James covers private equity for The Wall Street Journal. He is particularly interested in matters related to limited partners, fundraising and the secondary market.

Star Union Dai-ichi - Wealth Builder - Growth Plus Fund: Get the Latest NAV Value, Performance and Returns of Star Union Dai-ichi - Wealth Builder - Growth Plus Fund.

Star Union Dai-ichi - New Dhan Suraksha Premium - Apex Growth: Get the Latest NAV Value, Performance and Returns of Star Union Dai-ichi - New Dhan Suraksha Premium - Apex Growth.